ES2149279T3 - Sistema terapeutico para el tratamiento de la psoriasis. - Google Patents

Sistema terapeutico para el tratamiento de la psoriasis.

Info

Publication number
ES2149279T3
ES2149279T3 ES94924861T ES94924861T ES2149279T3 ES 2149279 T3 ES2149279 T3 ES 2149279T3 ES 94924861 T ES94924861 T ES 94924861T ES 94924861 T ES94924861 T ES 94924861T ES 2149279 T3 ES2149279 T3 ES 2149279T3
Authority
ES
Spain
Prior art keywords
pct
treatment
therapeutic system
sec
psoriasis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES94924861T
Other languages
English (en)
Inventor
Harald List
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LTS Lohmann Therapie Systeme AG
Original Assignee
LTS Lohmann Therapie Systeme AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by LTS Lohmann Therapie Systeme AG filed Critical LTS Lohmann Therapie Systeme AG
Application granted granted Critical
Publication of ES2149279T3 publication Critical patent/ES2149279T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

SE DESCRIBE UN SISTEMA TERAPEUTICO PARA APLICACION TOPICA DE SUSTANCIAS ACTIVAS EN EL TRATAMIENTO DE ENFERMEDADES DE LA PIEL QUE INCLUYEN PROLIFERACION DE CELULAS PRONUNCIADAS. EL SISTEMA SE CARACTERIZA POR EL HECHO DE QUE LA SUSTANCIA ACTIVA EN CUESTION ES UN DERIVADO ACEPTABLE FARMACEUTICAMENTE DE LA VITAMINA D 3, CON LA EXCEPCION DE TALES DERIVADOS DE LA VITAMINA D 3, QUE SIRVEN PARA LA REGULACION DEL METABOLISMO DE CALCIO.
ES94924861T 1993-08-21 1994-08-10 Sistema terapeutico para el tratamiento de la psoriasis. Expired - Lifetime ES2149279T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4328217A DE4328217C2 (de) 1993-08-21 1993-08-21 Therapeutisches System zur Behandlung der Psoriasis

Publications (1)

Publication Number Publication Date
ES2149279T3 true ES2149279T3 (es) 2000-11-01

Family

ID=6495752

Family Applications (1)

Application Number Title Priority Date Filing Date
ES94924861T Expired - Lifetime ES2149279T3 (es) 1993-08-21 1994-08-10 Sistema terapeutico para el tratamiento de la psoriasis.

Country Status (11)

Country Link
US (1) US5695778A (es)
EP (1) EP0714304B1 (es)
JP (1) JPH09506331A (es)
AT (1) ATE193651T1 (es)
CA (1) CA2168882A1 (es)
DE (2) DE4328217C2 (es)
DK (1) DK0714304T3 (es)
ES (1) ES2149279T3 (es)
GR (1) GR3034338T3 (es)
PT (1) PT714304E (es)
WO (1) WO1995005829A1 (es)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0711558A1 (en) * 1994-10-21 1996-05-15 Unilever Plc Compositions for topical application to skin, hair and nails
DK128494A (da) * 1994-11-08 1996-05-09 Edel K Seidenschnur Behandling af keratinøse og psoriatiske sygdomstilstande med neglelak indeholdende vitamin D metabolit, eller derivat, og/eller vitamin A derivat
DE19736265C2 (de) * 1997-08-15 2002-10-31 Phytexpert Pharm Tox Consultin Arzneimittel zur Behandlung von Hauterkrankungen
US8263580B2 (en) * 1998-09-11 2012-09-11 Stiefel Research Australia Pty Ltd Vitamin formulation
RU2003115307A (ru) * 2000-10-23 2004-11-10 Хантсмэн Интернэшнл Ллс (Us) Герметизирующие композиции с высокими эксплуатационными характеристиками на основе форполимеров меди метандифенилдиизоцианатных
ES2298264T3 (es) * 2000-10-27 2008-05-16 Leo Pharma A/S Composicion topica que contiene al menos una vitamina d o un analogo de vitamina d y al menos un corticoesteroide.
KR100438254B1 (ko) * 2001-03-29 2004-07-02 아이큐어 주식회사 비타민 ｄ 유사체를 포함하는 매트릭스형 경피흡수제제
AU2002368245A1 (en) * 2002-09-26 2004-04-19 Young-Kweon Choi Matrix type patch for transdermal administration of vitamin d analog and the use thereof
WO2004112860A1 (ja) * 2003-06-18 2004-12-29 Hokkaido Technology Licensing Office Co., Ltd. 細胞接着・増殖性材料
WO2005102296A2 (en) * 2004-04-23 2005-11-03 Heptagen Limited Combinations for the treatment of immunoproliferative skin disorders such as psoriasis
JP5612263B2 (ja) * 2005-06-01 2014-10-22 スティーフェル リサーチ オーストラリア ピーティーワイ リミテッド ビタミン製剤
KR20170023776A (ko) 2014-02-26 2017-03-06 루마 세러퓨틱스 인코포레이티드 자외선 광선 치료 장치들 및 방법들
CN109310527A (zh) 2016-02-09 2019-02-05 鲁玛治疗公司 用于通过光疗法来治疗牛皮癣的方法、组合物和设备
US11014119B2 (en) * 2019-02-28 2021-05-25 Kiss Nail Products, Inc. Dispensing lid and container

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3854480A (en) * 1969-04-01 1974-12-17 Alza Corp Drug-delivery system
DE3315272C2 (de) * 1983-04-27 1986-03-27 Lohmann Gmbh & Co Kg, 5450 Neuwied Pharmazeutisches Produkt und Verfahren zu seiner Herstellung
JPH07100685B2 (ja) * 1985-08-02 1995-11-01 レオ・ファ−マシュ−ティカル・プロダクツ・リミテッド・エイ／エス（レ−ベンス・ケミスケ・ファブリック・プロデュクチオンスアクチ−セルスカブ） 新規ビタミンｄ類似体
USRE34692E (en) * 1987-07-09 1994-08-09 Lts Lohmann Therapi-Systeme Gmbh & Co. Kg Transdermal therapeutic system
WO1989010351A1 (en) * 1988-04-21 1989-11-02 Leo Pharmaceutical Products Ltd. A/S (Løvens Kemis Novel vitamin d analogues
US5098899A (en) * 1989-03-06 1992-03-24 Trustees Of Boston University Method for therapeutically treating psoriatic arthritis using vitamin D analogues and metabolites
US5246925A (en) * 1989-03-09 1993-09-21 Wisconsin Alumni Research Foundation 19-nor-vitamin D compounds for use in treating hyperparathyroidism
GB8915770D0 (en) * 1989-07-10 1989-08-31 Leo Pharm Prod Ltd Chemical compounds
DE3933034A1 (de) * 1989-10-02 1991-04-11 Schering Ag 24-homo-vitamin-d-derivate, verfahren zu ihrer herstellung
US5532228A (en) * 1990-02-06 1996-07-02 Schering Aktiengesellschaft Side-chain homologous vitamin D derivatives, process for their production, pharmaceutical preparations containing these derivatives and their use as pharmaceutical agents
EP0474517B1 (en) * 1990-09-07 1998-11-18 Wisconsin Alumni Research Foundation Novel use of 1alpha-hydroxylated-19-nor-vitamin D compounds to treat psoriasis
DE69214617T2 (de) * 1991-12-26 1997-05-28 Wisconsin Alumni Res Found 26,27-Dimethylen-1-Alpha, 25-Dihydroxyvitamin-D2 und 26,27-Dihydroxyvitamin-D2 und Verfahren zu ihrer Herstellung

Also Published As

Publication number Publication date
EP0714304A1 (de) 1996-06-05
GR3034338T3 (en) 2000-12-29
DE59409394D1 (de) 2000-07-13
ATE193651T1 (de) 2000-06-15
PT714304E (pt) 2000-11-30
WO1995005829A1 (de) 1995-03-02
EP0714304B1 (de) 2000-06-07
CA2168882A1 (en) 1995-03-02
US5695778A (en) 1997-12-09
JPH09506331A (ja) 1997-06-24
DE4328217A1 (de) 1995-02-23
DK0714304T3 (da) 2000-10-16
DE4328217C2 (de) 1996-01-11

Similar Documents

Publication Publication Date Title
Calzavara-Pinton et al. A retrospective analysis of real-life practice of off-label photodynamic therapy using methyl aminolevulinate (MAL-PDT) in 20 Italian dermatology departments. Part 1: inflammatory and aesthetic indications
ES2164097T3 (es) Uso de anestesicos topicos para la fabricacion de un medicamento para el tratamiento del asma bronquial.
AU761947B2 (en) Skin and tissue care and/or treatment agent
ES2149279T3 (es) Sistema terapeutico para el tratamiento de la psoriasis.
GEP20043216B (en) Orally Administered Controlled Drug Delivery System
ES2074698T3 (es) Composicion oral para el tratamiento de enfermedades intestinales inflamatorias.
BR9908030A (pt) Composição farmacêutica compreendendo uma ou mais unidades de dose oralmente ministráveis, e, processos para prepará-la, para uso da mesma, e para tratar uma condição ou distúrbio médico em um indivìduo em que tratamento com um inibidor da ciclooxigenase-2 é indicado
AR012172A2 (es) Composiciones farmaceuticas que comprenden analogos de lactacistina y uso de los mismos para la fabricacion de un medicamento
DE69434211D1 (de) Phenylacetate und derivate, allein oder in kombination mit anderen verbindungen, zur behandlung von neoplastischen und anderen erkrankungen
CA2267049A1 (en) Pharmaceutical compositions
MXPA04000654A (es) Terapia dermica usando derivados de fosfato de agente de transferencia de electrones.
ES2178048T3 (es) Uso de rifaximina como medicamento para el tratamiento de diarrea por criptosporidiosis.
CA2091200A1 (en) Topical composition for relieving aches and pains
DK0785769T3 (da) Terapeutisk vitamin-calcium-kombination i form af en galenisk enhedsdosistablet, fremgangsmåde til fremstilling af denne sa
AR006401A1 (es) Compuestos de pirrolopirrolona, una composicion farmaceutica que los contiene, su uso en la fabricacion de un medicamento y en terapia, procesospara su preparación y compuestos intermediarios para dichos procesos.
DE68912195T2 (de) Verwendung von Pyrrolicloncarbonsäurealkylestern zur Herstellung eines Arzneimittels zur Behandlung von Ichtyosis.
AR026197A1 (es) Uso de dipiridamol o mopidamol para el tratamiento y prevencion de trastornos de la microcirculacion dependientes de fibrina
IT1170214B (it) Composizione farmaceutica per la cura delle arteriopatie periferiche
ES2147788T3 (es) 3,4-diarilcromanos para el tratamiento de la dermatitis.
ATE77230T1 (de) Melatoninhaltige mittel sowie deren verwendungen.
Nocera et al. Benefits of Avène thermal hydrotherapy in chronic skin diseases and dermatological conditions: An overview
WO1987000432A3 (en) Use of melatonin or related compounds for the treatment of psoriasis
KR910005858A (ko) 지방산 요법
GB2431581A (en) Ozonated oil formulations
ATE237331T1 (de) Deuterierte wirkstoffe in transdermaler applikation

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 714304

Country of ref document: ES